5521 - 5530 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Could Soluble Amyloid Be Neuroprotective Rather Than Toxic?Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,17End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792796.54034.5fCitation Count: 0
-
RESTRICTEDTitle: New Questions About a Mysterious Neurologic Cluster in CanadaJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 17Start Page: 1,20End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000792776.14362.2bCitation Count: 0
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 4
-
OPENTitle: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 788End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28500Citation Count: 1
- Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of Gait2021OPENTitle: Dual Task Turning in Place: A Reliable, Valid, and Responsive Outcome Measure of Freezing of GaitJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 269End Page: 278Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28887Citation Count: 23
-
OPENTitle: THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a TrialJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 410End Page: 415Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28840Best OA location URL: https://hal.sorbonne-universite.fr/hal-03416717Citation Count: 10
-
OPENTitle: Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo‐Controlled Trial of RasagilineJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 325End Page: 333Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28838Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9019575Citation Count: 15
-
RESTRICTEDTitle: Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive SeverityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 427End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28829Citation Count: 9
-
RESTRICTEDTitle: The South African Parkinson's Disease Study CollectionJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 230End Page: 232Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28828Citation Count: 4